4.07MMarket Cap-258P/E (TTM)
5.7700High5.6750Low685Volume5.4700Open5.5000Pre Close3.92KTurnover0.18%Turnover RatioLossP/E (Static)716.45KShares18.600052wk High1.16P/B2.17MFloat Cap4.320052wk Low--Dividend TTM381.60KShs Float2052.0000Historical High--Div YieldTTM1.73%Amplitude4.3200Historical Low5.7220Avg Price1Lot Size
Evoke Pharma Stock Forum
NEWS
Evoke Pharma Reports First Quarter 2024 Financial Results
Positive
114% year-over-year increase in net product sales to $1.7 million.
70% growth in prescriber numbers in Q1 2024 compared to Q4 2023.
Net revenue guidance for 2024 reaffirmed at $14 million.
Reduction in net loss to $1.6 million from $2.2 million in Q1 2023.
Raised $8.8 million through a public offering in Q1 2024.
Partnership with ASPN Pharmacies expected to enhance service delivery and patient reach.
...
SEC announcement· 1 min ago
2023 was a year full of tears and fun. Tear because of the leak of knowledge and trade with emotional. Fun because of earning a bit at the end of 2023. Thanks to Moomoo, provided an endless course, technique to equip me with correct trading direction without any more emotional.
My biggest lost is Evoke Pharma due to me as a fresh one trading with emotional.
Thanks for QQQ, I gained a bit to recover my loss.
Look ahead more gaining in 2024.
3 MINUTES AGO, 8:30 AM EST
VIA GLOBENEWSWIRE
2 MINUTES AGO, 8:30 AM EST
VIA GLOBENEWSWIRE
No comment yet